A Model-Based Pharmacokinetic/Pharmacodynamic Analysis of the Combination of Amoxicillin and Monophosphoryl Lipid A Against <i>S. pneumoniae</i> in Mice

• Ngā kaituhi matua: Sebastian Franck (Author), Robin Michelet (Author), Fiordiligie Casilag (Author), Jean-Claude Sirard (Author), Sebastian G. Wicha (Author), Charlotte Kloft (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2021-03-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Combining amoxicillin with the immunostimulatory toll-like receptor 4 agonist monophosphoryl lipid A (MPLA) represents an innovative approach for enhancing antibacterial treatment success. Exploiting pharmacokinetic and pharmacodynamic data from an infection model of <i>Streptococcus pneumonia...